Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:02 PM
Ignite Modification Date:
2025-12-26 @ 4:02 PM
NCT ID:
NCT06997406
Eligibility Criteria:
Inclusion Criteria:
* Patients aged between 18 and 75 years
* Patients diagnosed with sudden sensorineural hearing loss as determined by the principal or sub-investigator
* Average hearing threshold in the affected ear ≥ 60 dB
* Initiation of treatment within two weeks of hearing loss onset
Exclusion Criteria:
* Patients with congenital or hereditary hearing loss
* Patients with fluctuating hearing loss
* Patients currently participating in other interventional treatments for sudden hearing loss
* Patients who have undergone surgery on the affected ear
* Patients with neurological or psychiatric disorders
* Patients with heart failure or ischemic heart disease
* Patients with immunodeficiency
* Patients with vestibular schwannoma (acoustic neuroma)
* Patients with other internal medical conditions deemed by the investigator to potentially interfere with the study conduct or outcomes
* Pregnant patients
* Patients with a known allergy to the investigational product
* Patients currently using acetylcysteine or products containing ginkgo biloba extract
* Patients with autoimmune diseases or currently receiving immunosuppressive therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06997406
Study Brief:
Protocol Section:
NCT06997406